Involvement of phospholipase A2 and lipoxygenase in lipopolysaccharide-induced inducible nitric oxide synthase expression in glial cells

GLIA

Volumn 51, Issue 1, 2005, Pages 13-21

  Won, Je Seong ^a   Im, Yeong Bin ^a   Khan, Mushfiquddin ^a   Singh, Avtar K ^a,b   Singh, Inderjit ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

12 LO; 5 LO; COX; Glial cells; iNOS; NF B; Nitric oxide; PLA2

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; BAICALEIN; BROMOENOL LACTONE; FLUOROPHOSPHATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; LIPOXYGENASE; LIPOXYGENASE INHIBITOR; METHYL ARACHIDONYL FLUOROPHOSPHATE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NORDIHYDROGUAIARETIC ACID; PHOSPHOLIPASE A2; UNCLASSIFIED DRUG; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; ENZYME INHIBITOR; ISOENZYME; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT; PHOSPHOLIPASE A; RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DRUG INHIBITION; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; GLIA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL LINE; CELL NUCLEUS; DRUG ANTAGONISM; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; GLIA; METABOLISM; NORTHERN BLOTTING; REPORTER GENE; TUMOR CELL LINE;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; BLOTTING, NORTHERN; CELL LINE; CELL LINE, TUMOR; CELL NUCLEUS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME INDUCTION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, REPORTER; ISOENZYMES; LIPOPOLYSACCHARIDES; LIPOXYGENASE; NEUROGLIA; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHOLIPASES A; RATS; RNA; TRANSFECTION;

EID: 22444448496     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.20178     Document Type: Article

References (58)

1. 2 by bromoenol lactone and trifluoromethyl ketones. J Biol Chem 270:445-450.
2. Aktan S, Aykut C, Yegen BC, Okar I, Ozkutlu U, Ercan S. 1993. The effect of nordihydroguaiaretic acid on leukotriene C4 and prostaglandin E2 production following different reperfusion periods in rat brain after forebrain ischemia correlated with morphological changes. Prostaglandins Leukot Essent Fatty Acids 49:633-641.
3. Arai K, Ikegaya Y, Nakatani Y, Kudo I, Nishiyama N, Matsuki N. 2001. Phospholipase A2 mediates ischemic injury in the hippocampus: a regional difference of neuronal vulnerability. Eur J Neurosci 13: 2319-2323
4. 2 stimulates inducible nitric oxide synthase expression via ERK and NF-kappaB in macrophages. Eur J Immunol 31:2709-2717.
5. Balsinde J, Dennis EA. 1996. Bromoenol lactone inhibits magnesium-dependent phosphatidate phosphohydrolase and blocks triacylglycerol biosynthesis in mouse P388D1 macrophages. J Biol Chem 271:31937-31941.
6. 2 blocks phospholipid fatty acid remodeling in murine P388D1 macrophages. J Biol Chem 272:29317-29321.
7. Beck KF, Sterzel RB. 1996. Cloning and sequencing of the proximal promoter of the rat iNOS gene: activation of NFkappaB is not sufficient for transcription of the iNOS gene in rat mesangial cells. FEBS Lett 394:263-267.
8. Billah MM, Eckel S, Mullmann TJ, Egan RW, Siegel MI. 1989. Phosphatidylcholine hydrolysis by phospholipase D determines phosphatidate and diglyceride levels in chemotactic peptide-stimulated human neutrophils. Involvement of phosphatidate phosphohydrolase in signal transduction. J Biol Chem 264:17069-17077.
9. Bjorkman DJ. 1998. The effect of aspirin and nonsteroidal anti-inflammatory drugs on prostaglandins. Am J Med 105:8S-12S.
10. Bourgoin S, Plante E, Gaudry M, Naccache PH, Borgeat P, Poubelle PE. 1990. Involvement of a phospholipase D in the mechanism of action of granulocyte-macrophage colony-stimulating factor (GM-CSF): priming of human neutrophils in vitro with GM-CSF is associated with accumulation of phosphatidic acid and diradylglycerol. J Exp Med 172:767-777.
11. Chen CC, Chiu KT, Sun YT, Chen WC. 1999. Role of the cyclic AMP-protein kinase A pathway in lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages. Involvement of cyclooxygenase-2. J Biol Chem 274:31559-31564.
12. Chen YC, Shen SC, Chen LG, Lee TJ, Yang LL. 2001. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochem Pharmacol 61:1417-1427.
13. Cui XL, Douglas JG. 1997. Arachidonic acid activates c-jun N-terminal kinase through NADPH oxidase in rabbit proximal tubular epithelial cells. Proc Natl Acad Sci USA 94:3771-3776.
14. Dignam JD, Lebovitz RM, Roeder RG. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489.
15. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE. 1998. Cyclooxygenase in biology and disease. FASEB J 12:1063-1073.
16. Engels F, Nijkamp FP. 1998. Pharmacological inhibition of leukotriene actions. Pharm World Sci 20:60-65.
17. Feinmark SJ, Cornicelli JA. 1997. Is there a role for 15-lipoxygenase in atherogenesis? Biochem Pharmacol 54:953-959.
18. Ferrante A, Hii CST, Huang ZH, Rathjen DA. 1999. The neutrophils: new outlook for old cells. London: Imperial College Press.
19. 15N]nitrate in biological fluids. Anal Biochem 126:131-138.
20. Harris SG, Padilla J, Koumas L, Ray D, Phipps RP. 2002. Prostaglandins as modulators of immunity. Trends Immunol 23:144-150.
21. Hashimoto T, Kihara M, Yokoyama K, Fujita T, Kobayashi S, Matsushita K, Tamura K, Hirawa N, Toya Y, Umemura S. 2003. Lipoxygenase products regulate nitric oxide and inducible nitric oxide synthase production in interleukin-1beta stimulated vascular smooth muscle cells. Hypertens Res 26:177-184.
22. Hii CS, Ferrante A, Edwards YS, Huang ZH, Hartfield PJ, Rathjen DA, Poulos A, Murray AW. 1995. Activation of mitogen-activated protein kinase by arachidonic acid in rat liver epithelial WB cells by a protein kinase C-dependent mechanism. J Biol Chem 270:4201-4204.
23. Hii CS, Huang ZH, Bilney A, Costabile M, Murray AW, Rathjen DA, Der CJ, Ferrante A. 1998. Stimulation of p38 phosphorylation and activity by arachidonic acid in HeLa cells, HL60 promyelocytic leukemic cells, and human neutrophils. Evidence for cell type-specific activation of mitogen-activated protein kinases. J Biol Chem 273: 19277-19282.
24. Hori M, Kita M, Torihashi S, Miyamoto S, Won KJ, Sato K, Ozaki H, Karaki H. 2001. Upregulation of iNOS by COX-2 in muscularis resident macrophage of rat intestine stimulated with LPS. Am J Physiol Gastrointest Liver Physiol 280:G930-938.
25. 2 in postmortem white matter from patients with multiple sclerosis. Neurochem Res 20:1335-1343.
26. Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME. 1997. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 17:9157-9164.
27. Kanaho Y, Kanoh H, Saitoh K, Nozawa Y. 1991. Phospholipase D activation by platelet-activating factor, leukotriene B4, and formyl-methionyl-leucyl- phenylalanine in rabbit neutrophils. Phospholipase D activation is involved in enzyme release. J Immunol 146:3536-3541.
28. Kuhn H, Chan L. 1997. The role of 15-lipoxygenase in atherogenesis: pro- and antiatherogenic actions. Curr Opin Lipidol 8:111-117.
29. 2 by methyl arachidonyl fluorophosphonate. Biochim Biophys Acta 1302:55-60.
30. Liu B, Gao HM, Wang JY, Jeohn GH, Cooper CL, Hong JS. 2002. Role of nitric oxide in inflammation-mediated neurodegeneration. Ann NY Acad Sci 962:318-331.
31. Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, Murphy WJ. 1993. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by Interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA 90:9730-974.
32. 2. Prog Nucleic Acid Res Mol Biol 67:1-33.
33. 2 in the macrophage antiviral response of inducible nitric-oxide synthase expression. J Biol Chem 277:38449-38455.
34. Marks-Konczalik J, Chu SC, Moss J. 1998. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites. J Biol Chem 273:22201-22208.
35. 2 on arachidonic acid release induced by reactive oxygen species. Arch Biochem Biophys 392:257-262.
36. McCarthy KD, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
37. 2 activity in adult rat ventricular myocytes. Am J Physiol 272(Pt 1): C450-456.
38. Meade EA, Smith WL, DeWitt DL. 1993. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 268: 6610-6614.
39. Minagar A, Shapshak P, Fujimura R, Ownby R, Heyes M, Eisdorfer C. 2002. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci 202:13-23.
40. Minghetti L, Nicolini A, Polazzi E, Creminon C, Maclouf J, Levi G. 1997. Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors. Glia 19:152-160.
41. 2+. FEBS Lett 192:189-193.
42. Nathoo N, Barnett GH, Golubic M. 2004. The eicosanoid cascade: possible role in gliomas and meningiomas. J Clin Pathol 57:6-13.
43. Pahan K, Namboodiri AM, Sheikh FG, Smith BT, Singh I. 1997. Increasing cAMP attenuates induction of inducible nitric-oxide synthase in rat primary astrocytes. J Biol Chem 272:7786-7791.
44. 2 to the nuclear fraction upon macrophage activation. Biochem Biophys Res Commun 196:147-153.
45. Ramasamy S, Drummond GR, Ahn J, Storek M, Pohl J, Parthasarathy S, Harrison DG. 1999. Modulation of expression of endothelial nitric oxide synthase by nordihydroguaiaretic acid, a phenolic antioxidant in cultured endothelial cells. Mol Pharmacol 56:116-123.
46. Rizzo MT, Carlo-Stella C. 1996. Arachidonic acid mediates interleukin-1 and tumor necrosis factor-alpha- induced activation of the c-jun amino-terminal kinases in stromal cells. Blood 88:3792-3800.
47. Robinson BS, Hu CS, Poulos A, Ferrante A. 1997. Activation of neutral sphingomyelinase in human neutrophils by polyunsaturated fatty acids. Immunology 91:274-280.
48. Sala A, Zarini S, Bolla M. 1998. Leukotrienes: lipid bioeffectors of inflammatory reactions. Biochemistry (Mosc) 63:84-92.
49. Shimpo M, Ikeda U, Maeda Y, Ohya K, Murakami Y, Shimada K. 2000. Effects of aspirin-like drugs on nitric oxide synthesis in rat vascular smooth muscle cells. Hypertension 35:1085-1091.
50. 2 is in the nucleus of subconfluent endothelial cells but confined to the cytoplasm of confluent endothelial cells and redistributes to the nuclear envelope and cell junctions upon histamine stimulation. Lab Invest 74:684-695.
51. Steer SA, Moran JM, Maggi LB Jr, Buller RM, Perlman H, Corbett JA. 2003. Regulation of cyclooxygenase-2 expression by macrophages in response to double-stranded RNA and viral infection. J Immunol 170: 1070-1076.
52. 2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol Dis 3:51-63.
53. Takahashi N, Hayano T, Suzuki M. 1989. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature 337: 473-475.
54. 2 block TNF-induced activation of transcription factor nuclear factor-kappa B and expression of ICAM-1. J Immunol 161:3421-3430.
55. Thompson NT, Bonser RW, Garland LG. 1991. Receptor-coupled phospholipase D and its inhibition. Trends Pharmacol Sci 12:404-408.
56. Vane JR, Bakhle YS, Botting RM. 1998. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38:97-120.
57. Won JS, Lee JK, Suh HW. 2001. Forskolin inhibits expression of inducible nitric oxide synthase mRNA via inhibiting the mitogen activated protein kinase in C6 cells. Brain Res Mol Brain Res 89:1-10.
58. Won JS, Im YB, Key L, Singh I, Singh AK. 2003. The involvement of glucose metabolism in the regulation of inducible nitric oxide synthase gene expression in glial cells: possible role of glucose-6-phosphate dehydrogenase and CCAAT/enhancing binding protein. J Neurosci 23:7470-7478.